EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Effect of GlucoSEB™ Supplement on the Blood Glucose Level in Diabetic Patients: A Case Study

Ankit Rathi, Ravikiran Pagare, Mayur Agrawal

Diabetes Research - Open Journal · 2024

DOI: 10.17140/droj-10-159 ↗
AbstractBibliografische Angaben

Abstract

Diabetes is becoming a globally prevalent disease that puts a burden on healthcare systems and poses challenges to risk management.Diabetes leads to microvascular and macrovascular complications. Therefore, maintaining normoglycemia is essential to improvingthe quality of life and preventing morbidity and mortality in people with diabetes (PwD). A current study was performedto check the effect of GlucoSEB™ supplement on the blood glucose level of Type 2 diabetes mellitus (T2DM) patients. Subjectsin this study were blinded to the treatment; they received a placebo for the initial seven days, followed by GlucoSEB™ for the nextseven days. Blood glucose was monitored with a continuous glucose monitoring (CGM) device. Administration of GlucoSEB™caused a decrease in blood glucose level, glucose area under the curve (AUC), and an improvement in time in range (TIR). Also,GlucoSEB™ was well tolerated by all the patients, indicating the safety of the supplement. Thus, GlucoSEB™ supplementationpositively influenced blood glucose parameters and helped curb blood glucose excursions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →